How dangerous are India’s generic drugs? Very


India relies on the weak oversight of developing countries that make up the bulk of its exports – that’s how it can continue to push substandard and often deadly medicines there. — Bloomberg

FOR a nation that seeks to claim the mantle of “pharmacy to the world,” India is scandalously short on regulatory oversight.

In the last six months, its generic cough syrups have killed dozens of children, its eye drops have caused blindness and its chemotherapy drugs have been contaminated.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
India , genericdrugs , regulation , oversight , scandals

Next In Business News

ES Sunlogy secures RM22.3mil sub-contract in Penang
Vestland terminates three affordable housing contracts worth RM550.7mil
Pestec appoints Adam Yee as president
Wawasan Dengkil and Kester partner on renewable energy projects
Binastra's unit inks tripartite agreement involving RM305mil contract
Ringgit ends lower as firmer US dollar weighs on market
Infomina posts higher 2Q profit, declares 1.35 sen dividend
SkyGate acquires property investment firm for RM76mil
Berjaya Land proposes name change to Berjaya Property
SCIB shareholders approve rights issue, share capital reduction

Others Also Read